Daniel J. Haraf to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Daniel J. Haraf has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.013
-
Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure. Oncologist. 2003; 8(4):350-60.
Score: 0.013